本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zentalis Pharmaceuticals, LLC

1.47
+0.11008.09%
成交量:160.85万
成交额:233.15万
市值:1.06亿
市盈率:-0.63
高:1.48
开:1.39
低:1.36
收:1.36
数据加载中...
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/10/11

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/10/06

重要事件披露

Form 8-K - Current report
2023/10/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/10/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/13

重要事件披露

Form 8-K - Current report
2023/09/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities